This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Aileron Therapeutics, Inc.. Active years: 2015-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2019
Title: Scott Paul Lentini: Innovator in Peptidomimetic Macrocycles
Introduction
Scott Paul Lentini is a notable inventor based in North Weymouth, MA (US). He has made significant contributions to the field of medicinal chemistry, particularly through his work on peptidomimetic macrocycles. With a total of 2 patents, Lentini's innovations are paving the way for new treatments in various diseases.
Latest Patents
Lentini's latest patents include the development of triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles. These patents provide methods for using such macrocycles in the treatment of diseases, showcasing his commitment to advancing medical science.
Career Highlights
Currently, Scott Paul Lentini is associated with Aileron Therapeutics, Inc., where he continues to push the boundaries of innovation in drug development. His work is characterized by a focus on creating effective therapeutic solutions that can significantly impact patient care.
Collaborations
Lentini collaborates with talented professionals in his field, including Vincent Guerlavais and Christopher R Conlee. These partnerships enhance the research and development process, leading to more robust and effective innovations.
Conclusion
Scott Paul Lentini's contributions to the field of medicinal chemistry through his patents and collaborations highlight his role as a key innovator. His work continues to inspire advancements in the treatment of diseases, making a lasting impact on healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile